Reply to risk of mortality in patients with cancer who experience febrile neutropenia
Publication
, Journal Article
Lyman, GH; Michels, SL; Barron, R
Published in: Cancer
November 15, 2011
Duke Scholars
Published In
Cancer
DOI
EISSN
1097-0142
ISSN
0008-543X
Publication Date
November 15, 2011
Volume
117
Issue
22
Start / End Page
5246
Related Subject Headings
- Oncology & Carcinogenesis
- 4206 Public health
- 3211 Oncology and carcinogenesis
- 1117 Public Health and Health Services
- 1112 Oncology and Carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Lyman, G. H., Michels, S. L., & Barron, R. (2011). Reply to risk of mortality in patients with cancer who experience febrile neutropenia. Cancer, 117(22), 5246. https://doi.org/10.1002/cncr.26141
Lyman, G. H., S. L. Michels, and R. Barron. “Reply to risk of mortality in patients with cancer who experience febrile neutropenia.” Cancer 117, no. 22 (November 15, 2011): 5246. https://doi.org/10.1002/cncr.26141.
Lyman GH, Michels SL, Barron R. Reply to risk of mortality in patients with cancer who experience febrile neutropenia. Cancer. 2011 Nov 15;117(22):5246.
Lyman, G. H., et al. “Reply to risk of mortality in patients with cancer who experience febrile neutropenia.” Cancer, vol. 117, no. 22, Nov. 2011, p. 5246. Scopus, doi:10.1002/cncr.26141.
Lyman GH, Michels SL, Barron R. Reply to risk of mortality in patients with cancer who experience febrile neutropenia. Cancer. 2011 Nov 15;117(22):5246.
Published In
Cancer
DOI
EISSN
1097-0142
ISSN
0008-543X
Publication Date
November 15, 2011
Volume
117
Issue
22
Start / End Page
5246
Related Subject Headings
- Oncology & Carcinogenesis
- 4206 Public health
- 3211 Oncology and carcinogenesis
- 1117 Public Health and Health Services
- 1112 Oncology and Carcinogenesis